INKT ▲ +2.0% - MiNK Therapeutics, Inc. $INKT - MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026 02-OCT-2026 09:00 AM ET